English | 繁體

Search in the results

UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Nanoscale Metal-Organic Particles (NMOPs) with Rapid Clearance for MR Imaging Guided Photothermal Therapy Conference paper
Yang, Y., Liu, Z., Chen, M. W.. Nanoscale Metal-Organic Particles (NMOPs) with Rapid Clearance for MR Imaging Guided Photothermal Therapy[C], 2106.
Authors:  Yang, Y.;  Liu, Z.;  Chen, M. W.
Favorite |  | Submit date：2022/08/16
Nanoscale metal-organic particles  nanomedicine  Mn-IR825@PDA-PEG  
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China Journal article
Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China[J]. Diabetes Therapy, 2023, 14(1), 93-107.
Authors:  Liu, Lei;  Ruan, Zhen;  Ung, Carolina Oi Lam;  Zhang, Yawen;  Shen, Yang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2023/01/08
Cost-effectiveness Analysis  Type 2 Diabetes  Glucagon-like Peptide-1 Analogue  Semaglutide  Peg-loxenatide  China  
Nanoparticles Mediating the Sustained Release of Ginkgolide B Offer Improved Brain Accumulation and Anti-Parkinsonian Activity Conference paper
Zhao, Yuying, Xiong, Sha, Liu, Wei, Liu, Yao, Wang, Qun, Luo, Jingshan, Chen, Xiaojia, Chen, Tonakai. Nanoparticles Mediating the Sustained Release of Ginkgolide B Offer Improved Brain Accumulation and Anti-Parkinsonian Activity[C], Yantai:The 13th Chinese Pharmaceutical Conference, 2019.
Authors:  Zhao, Yuying;  Xiong, Sha;  Liu, Wei;  Liu, Yao;  Wang, Qun; et al.
Favorite |  | Submit date：2022/08/02
Parkinson's Disease  Peg-pcl Nanoparticles  Ginkgolide b  Oral Bioavailability  Anti-parkinsonian Efficacy  Brain Delivery  
Preparation and anti-tumor activity study of long-circulating, self-assembled gambogic acid nanoparticles 藤黄酸长循环纳米粒的制备及其抗肿瘤作用研究 Journal article
Guo M.-R., Wang F., Chen L.-J., Ouyang D.-F., Liu Y., Liang X., Zhang G.-L., Zhang J.-F., Liu H.-S.. Preparation and anti-tumor activity study of long-circulating, self-assembled gambogic acid nanoparticles 藤黄酸长循环纳米粒的制备及其抗肿瘤作用研究[J]. Chinese Journal of New Drugs, 2018, 27(14), 1639-1644.
Authors:  Guo M.-R.;  Wang F.;  Chen L.-J.;  Ouyang D.-F.;  Liu Y.; et al.
Favorite |  | Submit date：2019/01/15
Anti-tumor  Gambogic acid  Nanoparticles  PCL-PEG-PCL  
Simultaneous biodegradation of carbon tetrachloride and trichloroethylene in a coupled anaerobic/aerobic biobarrier Journal article
Kwon K, Shim H, Bae W, Oh J, Bae J. Simultaneous biodegradation of carbon tetrachloride and trichloroethylene in a coupled anaerobic/aerobic biobarrier[J]. Journal of Hazardous Materials, 2016, 313, 60-67.
Authors:  Kwon K;  Shim H;  Bae W;  Oh J;  Bae J
Favorite | TC[WOS]:22 TC[Scopus]:24  IF:12.2/11.9 | Submit date：2019/02/14
Carbon Tetrachloride  Coupled Removal  Peg Biobarrier  Toluene  Trichloroethylene  
Determination of six polyynes in Oplopanax horridus and Oplopanax elatus using polyethylene glycol modified reversed migration microemulsion electrokinetic chromatography Journal article
Yang, Zhong-mei, Zhao, Jing, Lao, Ka-meng, Chen, Xiao-jia, Leong, Fong, Wang, Chong-Zhi, Yuan, Chun-Su, Li, Shao-ping. Determination of six polyynes in Oplopanax horridus and Oplopanax elatus using polyethylene glycol modified reversed migration microemulsion electrokinetic chromatography[J]. Electrophoresis, 2014, 35(20), 2959-2964.
Authors:  Yang, Zhong-mei;  Zhao, Jing;  Lao, Ka-meng;  Chen, Xiao-jia;  Leong, Fong; et al.
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:3.0/2.8 | Submit date：2018/11/06
Oplopanax  Peg  Polyynes  Reversed Migration Meekc  
A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles Journal article
Mert O., Lai S.K., Ensign L., Yang M., Wang Y.-Y., Wood J., Hanes J.. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles[J]. Journal of Controlled Release, 2012, 157(3), 455-460.
Authors:  Mert O.;  Lai S.K.;  Ensign L.;  Yang M.;  Wang Y.-Y.; et al.
Favorite | TC[WOS]:94 TC[Scopus]:101 | Submit date：2019/01/16
Drug Delivery  Mucin  Peg  Vitamin e Tpgs  
Tolerability of hypodermic injection of pegfilgrastin (PEG-G-CSF) in a phase I study Journal article
Zheng L., Xu N., Liu C.-T., Wang Y., Luo Z., Luo H.. Tolerability of hypodermic injection of pegfilgrastin (PEG-G-CSF) in a phase I study[J]. Chinese Journal of Evidence-Based Medicine, 2008, 8(3), 155-158.
Authors:  Zheng L.;  Xu N.;  Liu C.-T.;  Wang Y.;  Luo Z.; et al.
Favorite |  | Submit date：2019/01/16
Pegfilgrastin (PEG-G-CSF)  Safety  Tolerance